{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T17:40:14Z","timestamp":1740246014255,"version":"3.37.3"},"reference-count":9,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.pnpbp.2010.06.026","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T08:40:09Z","timestamp":1278405609000},"page":"1353-1354","source":"Crossref","is-referenced-by-count":0,"title":["Reversible antipsychotic-associated leukopenia in a patient with splenomegalia"],"prefix":"10.1016","volume":"34","author":[{"given":"Tomislav","family":"Majic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Oldenkott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Behr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2010.06.026_bb0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"15;329","author":"Alvir","year":"1993","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pnpbp.2010.06.026_bb0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.pnpbp.2007.12.006","article-title":"Leucopenia and neutropenia secondary to a lymphoma in a patient exposed to several antipsychotics","volume":"1;32","author":"Chaves","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2010.06.026_bb0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1176\/appi.ajp.158.5.817","article-title":"Quetiapine and leukopenia","volume":"158","author":"Clark","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.06.026_bb0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1176\/ajp.155.6.855a","article-title":"Risperidone-associated agranulocytosis","volume":"155","author":"Finkel","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2010.06.026_bb0025","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1176\/appi.ajp.158.10.1736-a","article-title":"Agranulocytosis and neutropenia with typical and atypical neuroleptics","volume":"158","author":"Hong","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.06.026_bb0030","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.178.6.576-a","article-title":"Reintroduction of clozapine after diagnosis of lymphoma","volume":"178","author":"Hundertmark","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.06.026_bb0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pnpbp.2006.08.005","article-title":"Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia","volume":"31","author":"Stip","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2010.06.026_bb0040","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/archpsyc.1975.01760290084010","article-title":"Outpatient phenothiazine use and bone marrow depression. A report from the drug epidemiology unit and the Boston collaborative drug surveillance program","volume":"32","author":"Swett","year":"1975","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2010.06.026_bb0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0269881107081559","article-title":"Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report","volume":"22","author":"Yalcin","year":"2008","journal-title":"J Psychopharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610002435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610002435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T17:05:44Z","timestamp":1740243944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584610002435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0278584610002435"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.06.026","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}